Oxford and AstraZeneca resume COVID-19 vaccine trial

LONDON — Oxford University announced Saturday it was resuming a trial for a coronavirus vaccine it is developing with pharmaceutical company AstraZeneca, a move that comes days after the study was suspended following a reported side-effect in a U.K. patient.

In a statement, the university confirmed the restart across all of its U.K. clinical trial sites after regulators gave the go-ahead following the pause on Sunday.

“The independent review process has concluded and following the…

Read Full Article

LEAVE A REPLY

Please enter your comment!
Please enter your name here